WKResearcher profile · from public sources
Wei Kang
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
GPNMB+ fibroblasts crosstalk with gastric epithelium to activate a pro-stemness niche in gastric cancer through IGF1R/SRC/FOSL1 feedback loop.
Gut, Nov 2026
Publication
Mutant KRAS-m6A Epitranscriptome Axis Promotes Colorectal Cancer and is a Therapeutic Target.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), Sept 2026
Publication
Gastric cancer tertiary lymphoid structures in the muscularis propria are associated with therapy resistance and promote immunosuppression.
Nature communications, Sept 2026
Publication
CCL5 and GLUT1 define leader cells in collective invasion of colorectal cancer.
The Journal of pathology, Aug 2026
Publication
HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma.
Journal of experimental & clinical cancer research : CR, Jun 2026
Publication
Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010-2023.
Hepatology international, Jun 2026
Publication
TGM2-mediated serotonylation of GPX4 confers ferroptosis resistance to promote gastric tumorigenesis.
Cell discovery, Apr 2026
Publication
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.
Signal transduction and targeted therapy, Dec 2025
Publication
Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer.
Nature communications, Dec 2025
Publication
Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF-Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next-Generation Sequencing, and Fragmentomics.
Case reports in oncological medicine, Nov 2025
Publication
Spatial and functional dissection of cancer-associated fibroblasts-mediated immune modulation in H. pylori-associated gastric cancer.
Molecular cancer, Nov 2025
Publication
RNA m1A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target.
Cancer communications (London, England), Oct 2025
Publication
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.
Cancer research, Sept 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Chi Chun Wong directly.
- JYJun Yu1 works together here · 1 with Chi Chun Wong
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error